Skip to content

Addiction: all studies

Page 221 of 857: studies 2,201 to 2,210 of 8,563, newest first. Back to the addiction overview

Research

MDMA and psilocybin regulate oligodendrocyte-lineage cell numbers and anxiety-like behaviors in a rat model of fear.

Biological Psychiatry February 3, 2026 Mehmet Bostancıklıoğlu, Davut Sinan Kaplan, Ramazan Bal et al.

Psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) produce rapid, enduring therapeutic effects in post-traumatic stress disorder (PTSD); however, the underlying cellular mechanisms remain incompletely understood. This study investigated whether adult myelin plasticity contributes to the therapeutic actions of psilocybin and MDMA in a rat model of contextual fear conditioning. Adult male...

Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia

Psychedelics February 3, 2026 Sheida Shadani, Erika Greaves, Zane B. Andrews et al.

Psychedelics, particularly psilocybin, have shown therapeutic potential across several psychiatric conditions, including depression, anxiety, obsessive-compulsive disorder, and anorexia nervosa (AN). These disorders often share social deficits that may be effectively alleviated by psychedelics considering their use has been linked with emotional empathy and enhanced social cognition. However,...

Biological Versus Artificial Consciousness: Will The Two Ever Meet?

Neurology and Neuroscience February 2, 2026 W. Krömer

The present opinion article first discusses the fundamental basis of self-consciousness (self-awareness).The biological situation is then compared to artificial systems. Actually, the deficiencies of artificial systems will highlight the key features of biological systems. Biological self-consciousness requires an individual to whom something can become conscious, which basically depends on the...

DOI: 10.33425/2692-7918.1119 (opens in new tab) Full text (opens in new tab) Key lock Artificial life Component thermodynamics Software system +2

Effectiveness of intranasal esketamine in the treatment of patients with treatment-resistant depression: an observational study based on data collected in a Spravato treatment program at the Institute of Living, Hartford, CT.

Psychopharmacology February 2, 2026 Benjamin Anderson, Andrew Winokur, Grace J Chan 1 citation

Major Depressive Disorder is a common and disabling psychiatric illness whose pharmacological treatment options have historically been characterized by relatively low response rates. "Treatment-resistant depression" has emerged to describe patients whose depressive symptoms fail to respond to multiple courses of oral antidepressant medications. In 2019, the FDA approved intranasal esketamine as...

Stereoselective, sex-dependent 5-HT2A receptor modulation of cortical plasticity by MDMA in mice.

Neuropsychopharmacology February 2, 2026 Maya C Gaines-Smith, Justin M Silverman, Michael Fiorillo et al. 3 citations

The psychoactive entactogen 3,4-methylenedioxymethamphetamine (MDMA), widely known as a recreational drug, is gaining renewed attention as a potential psychotherapeutic adjunct for treatment-resistant psychiatric disorders, yet its neurobiological mechanisms - particularly those related to its stereoisomers and sex-specific effects - remain poorly understood. Here, we report stereoselective and...

Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.

Psychiatry Research February 2, 2026 Tatiana Aboulafia Brakha, Albert Buchard, Cédric Mabilais et al. 1 citation

Classic serotonergic psychedelics such as LSD and psilocybin show promising antidepressant effects in controlled trials, but real-world data from routine clinical care remain limited. This study retrospectively analysed routine data from adults with treatment-resistant depressive and/or anxiety disorders who received a first standardized Psychedelic-assisted Psychotherapy (PAP) cycle with 100...

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review.

Clinical Psychology Review February 2, 2026 Jolien K E Veraart, Nina Schimmers, Joost J. Breeksema et al. 4 citations

Ketamine-assisted psychotherapy (KAP) is considered a promising treatment strategy in psychiatric disorders, combining psychotherapeutic interventions with the rapid-acting pharmacological effects of ketamine towards enhancing outcomes. Although KAP has been practiced for many years across different diagnoses, evidence regarding optimal treatment methods and working mechanisms remains limited...

DOI: 10.1016/j.cpr.2026.102706 (opens in new tab) Full text (opens in new tab) Ketamine-assisted psychotherapy Psychiatric disorders Systematic review

THE 34 AXIOMS OF MUDAKKATTU SDEL: A UNIVERSAL META ONTOLOGY FOR THE UNIFICATION OF ALL FIELDS OF KNOWLEDGE

JOURNAL OF ADVANCE AND FUTURE RESEARCH February 1, 2026 Baby Sebastian Mundakkttu

The Mundakkttu Scale-Dependent Emergent Law (SDEL) Theory proposes a unified conceptual framework for understanding reality across physics, mathematics, life, consciousness, and ethics through a single foundational principle: interaction. The theory argues that laws of nature are not eternal or universal entities, but emergent, scale-dependent regularities arising from stable patterns of...

Perioperative Mindfulness Training Does Not Improve Sleep Quality in Patients Undergoing Total Knee Arthroplasty.

Arthroplasty today February 2026 Jessica L H Phillips, Makenna R Hemmerle, Roseann M Johnson et al.

Sleep quality declines in the immediate postoperative period following total knee arthroplasty (TKA). No prior study has prospectively analyzed the impact of mindfulness meditation (MM) on sleep quality following TKA. The purpose of this study was to determine whether MM administered in conjunction with TKA results in any improvement in Pittsburgh Sleep Quality Index (PSQI) at 2, 6, or 12 weeks...

Ketamine/esketamine treatment for resistant depression in children and adolescents: a PRISMA systematic review.

European Child & Adolescent Psychiatry February 2026 Konstantinos N Fountoulakis, Paraskevi Tatsiopoulou, Athanasios Saitis et al.

Ketamine and esketamine have been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior in adults. The current paper aimed to systematically review the available data on their efficacy in children and adolescents. The MEDLINE was searched with the keyword 'esketamine' on July 5th, 2024 (by following the PRISMA statement)....